REFERENCES
Wilson, J. M. Q. & Jungner, G. Principles and Practice of Screening for Disease (World Health Organization, Geneva, 1968)
American College of Medical Genetics. Newborn screening: toward a uniform screening panel and system. Genet. Med. 8 (Suppl. 1), 1–252 (2006)
Lund, A. M. Neonatal metabolic screening in Denmark [abstract K058.02V] in 101st Annual Meeting of the German Society of Pediatrics (29 Sep–2 Oct 2005, Bremen) [online], (2005)
Save Babies Through Screening Foundation of Canada. Diseases screened by province [online], (2006)
Moyer, V. A., Calonge, N., Teutsch, S. M. & Botkin, J. R. Expanding newborn screening: process, policy, and priorities. Hastings Cent. Rep. 38, 32–39 (2008)
Alexander, D. & van Dyck, P. C. A vision of the future of newborn screening. Pediatrics 117, 350–354 (2006)
Bailey, D. B. Jr, Skinner, D. & Warren, S. F. Newborn screening for developmental disabilities: reframing presumptive benefit. Am. J. Public Health 95, 1889–1893 (2005)
Bailey, D. B. Jr, Beskow, L. M., Davis, A. M. & Skinner, D. Changing perspectives on the benefits of newborn screening. Ment. Retard. Dev. Disabil. Res. Rev. 12, 270–279 (2006)
Health Council of the Netherlands. Screening: Between Hope and Hype (Health Council of the Netherlands, The Hague, 2008)
Miller, F. A., Robert, J. S. & Hayeems, R. Z. Questioning the consensus: managing carrier status results generated by newborn screening. Am. J. Public Health 99, 210–215 (2009)
Borry, P., Fryns, J. P., Schotsmans, P. & Dierickx, K. Carrier testing in minors: a systematic review of guidelines and position papers. Eur. J. Hum. Genet. 14, 133–138 (2006)
Hayeems, R. Z. et al. Informing parents about expanded newborn screening: influences on provider involvement. Pediatrics 124, 950–958 (2009)
Dhondt, J. L. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing. J. Pediatr. 147, S106–S108 (2005)
Liebl, B. et al. Very high compliance in an expanded MS-MS-based newborn screening program despite written parental consent. Prev. Med. 34, 127–131 (2002)
Faden, R., Chwalow, A. J., Holtzman, N. A. & Horn, S. D. A survey to evaluate parental consent as public policy for neonatal screening. Am. J. Public Health 72, 1347–1352 (1982)
Faden, R. R., Holtzman, N. A. & Chwalow, A. J. Parental rights, child welfare, and public health: the case of PKU screening. Am. J. Public Health 72, 1396–1400 (1982)
Knoppers, B. M. in New Horizons in Neonatal Screening: Proceedings of the 9th International Neonatal Screening Symposium & the 2nd Meeting of the International Society for Neonatal Screening, Lille, France, 13–17 September 1993 (eds Farriaux, J. P. & Dhondt, J.-L.) 15 (Elsevier Science, Amsterdam, 1994)
O'Connor, A., Légaré, F. & Stacey, D. Risk communication in practice: the contribution of decision aids. BMJ 327, 736–740 (2003)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bombard, Y., Miller, F., Hayeems, R. et al. The expansion of newborn screening: is reproductive benefit an appropriate pursuit?. Nat Rev Genet 10, 666–667 (2009). https://doi.org/10.1038/nrg2666
Issue Date:
DOI: https://doi.org/10.1038/nrg2666
- Springer Nature Limited
This article is cited by
-
Expanding the Australian Newborn Blood Spot Screening Program using genomic sequencing: do we want it and are we ready?
European Journal of Human Genetics (2023)
-
The promise of public health ethics for precision medicine: the case of newborn preventive genomic sequencing
Human Genetics (2022)
-
Primary care provider perspectives on using genomic sequencing in the care of healthy children
European Journal of Human Genetics (2020)
-
Ethics in genetic counselling
Journal of Community Genetics (2019)
-
Genomic newborn screening: public health policy considerations and recommendations
BMC Medical Genomics (2017)